600
Participants
Start Date
November 30, 1995
Study Completion Date
June 30, 1999
filgrastim
CMF regimen
cyclophosphamide
doxorubicin hydrochloride
fluorouracil
methotrexate
tamoxifen citrate
thiotepa
autologous bone marrow transplantation
peripheral blood stem cell transplantation
low-LET cobalt-60 gamma ray therapy
low-LET electron therapy
low-LET photon therapy
St. Vincent's Hospital, Dublin
Addenbrooke's NHS Trust, Cambridge
Cheltenham General Hospital, Cheltenham
Royal Devon and Exeter Hospital, Exeter
Royal Free Hospital, Hampstead, London
Northwick Park Hospital, Harrow
Huddersfield Royal Infirmary, Huddersfield, West Yorks
St. James's Hospital, Leeds
St. George's Hospital, London
Middlesex Hospital- Meyerstein Institute, London
Newcastle General Hospital, Newcastle upon Tyne
Nottingham City Hospital NHS Trust, Nottingham
Derriford Hospital, Plymouth
Weston Park Hospital, Sheffield
Royal South Hants Hospital, Southampton
Aberdeen Royal Infirmary, Aberdeen
Royal Infirmary, Edinburgh
Western General Hospital, Edinburgh
Beatson Oncology Centre, Glasgow
Royal Infirmary, Glasgow
Velindre Hospital, Cardiff
Scottish Cancer Therapy Network
OTHER